The estimated Net Worth of Azita Saleki Gerhardt is at least $43.5 Milhão dollars as of 21 February 2024. Azita Gerhardt owns over 52,870 units of Entegris Inc stock worth over $32,848,405 and over the last 12 years he sold ENTG stock worth over $10,383,147. In addition, he makes $219,973 as Independent Director at Entegris Inc.
Azita has made over 23 trades of the Entegris Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently he exercised 52,870 units of ENTG stock worth $3,112,986 on 21 February 2024.
The largest trade he's ever made was exercising 86,920 units of Entegris Inc stock on 24 May 2021 worth over $3,036,116. On average, Azita trades about 6,137 units every 81 days since 2013. As of 21 February 2024 he still owns at least 296,814 units of Entegris Inc stock.
You can see the complete history of Azita Gerhardt stock trades at the bottom of the page.
Dr. Azita Saleki-Gerhardt Ph.D. serves as Independent Director of the Company. Dr. Saleki-Gerhardt leads a team of more than 6,500 scientific, engineering, business, quality, supply chain, security, purchasing and manufacturing professionals responsible for the supply and distribution of all AbbVie products, as well as a number of enterprise-wide services. She is responsible for AbbVie's global manufacturing network, oversees relationships with more than 2,000 global suppliers, and manages a distribution network that spans 170 markets. She came to AbbVie through its 2013 spin-off from Abbott, which she joined in 1993 as a research scientist, assuming roles of increasing responsibility in pharmaceutical development, manufacturing technology and quality. Dr. Saleki-Gerhardt earned her bachelor's, master's, and doctorate degrees in pharmaceutics from the University of Wisconsin-Madison and has been awarded several patents related to pharmaceutical sciences. She is a member of the Chicago Network, serves on the board of United Way ofLake County, Illinois, is the Chair of the Global Quality and Manufacturing Committee for industry association PhRMA, and is a member of the School of Pharmacy Board of Visitors at the University of Wisconsin-Madison.
As the Independent Director of Entegris Inc, the total compensation of Azita Gerhardt at Entegris Inc is $219,973. There are 15 executives at Entegris Inc getting paid more, with Bertrand Loy having the highest compensation of $5,426,050.
Azita Gerhardt is 56, he's been the Independent Director of Entegris Inc since 2017. There are 13 older and 10 younger executives at Entegris Inc. The oldest executive at Entegris Inc is Michael Bradley, 71, who is the Independent Director.
Azita's mailing address filed with the SEC is North Waukegan Road, North Chicago, Lake County, Illinois, 60044, United States.
Over the last 22 years, insiders at Entegris Inc have traded over $248,785,588 worth of Entegris Inc stock and bought 1,851,237 units worth $14,687,360 . The most active insiders traders include Capital Corp Gmt, James Robert Anderson, eMichael A Bradley. On average, Entegris Inc executives and independent directors trade stock every 11 days with the average trade being worth of $3,478,026. The most recent stock trade was executed by Daniel D. Woodland on 11 July 2024, trading 15,000 units of ENTG stock currently worth $825,750.
for more than 40 years, entegris has been a provider of critical products and materials used in advanced high-technology manufacturing. these products and materials are often used to make the building blocks of many of the world's most complex microelectronic products, such as computers, mobile devices and phones, data storage components, televisions and monitors, and automobiles. headquartered in billerica, massachusetts, entegris employs approximately 3,500 people worldwide, with roughly half employed in asia-pacific or europe. with research and development, customer service, analytical labs, and manufacturing in asia-pacific, north america, and europe, entegris supports customers around the globe as they take technology to the next level.
Entegris Inc executives and other stock owners filed with the SEC include: